TP53 and hepatocellular carcinoma: MiR-205 may negatively regulate the protein levels of USP7 in HCC cells by targeting the 3'-untranslated region (3'-UTR) of USP7, thereby modulating the p53 signaling pathway and cellular proliferation levels47.